Skip to main content

Short Seller Andrew Left Goes Sour On Lemonade, Says Company Lies To Shareholders

Citron Research’s Andrew Left criticized insurance company Lemonade Inc. on Friday, saying its stock multiple is based on empty marketing tactics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.